Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
29.47
-0.43 (-1.44%)
Sep 4, 2026, 1:55 PM EDT - Market open

Zymeworks Revenue

Zymeworks had revenue of $3.23M in the quarter ending June 30, 2026, a decrease of -90.98%. This brings the company's revenue in the last twelve months to $35.77M, down -67.47% year-over-year. In the year 2025, Zymeworks had annual revenue of $105.97M with 38.87% growth.

Revenue (ttm)
$35.77M
Revenue Growth
-67.47%
P/S Ratio
56.86
Revenue / Employee
$160,723
Employees
231
Market Cap
2.09B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025105.97M29.66M38.87%
Dec 31, 202476.30M292.00K0.38%
Dec 31, 202376.01M-336.47M-81.57%
Dec 31, 2022412.48M385.80M1,446.03%
Dec 31, 202126.68M-12.27M-31.50%
Dec 31, 202038.95M9.41M31.84%
Dec 31, 201929.54M-23.48M-44.28%
Dec 31, 201853.02M1.26M2.43%
Dec 31, 201751.76M40.75M370.18%
Dec 31, 201611.01M1.35M13.96%
Dec 31, 20159.66M7.99M478.44%
Dec 31, 20141.67M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
ADMA Biologics512.28M
Aurinia Pharmaceuticals311.51M
Vericel306.30M
UroGen Pharma188.73M
Mesoblast120.25M
Nanobiotix38.27M
Generate Biomedicines26.48M
Zenas BioPharma1.00M
Revenue Rankings